* Newstin.com is for sale! * After achieving our strategic milestone, we are offering for sale: Newstin.com and all 14 related domains featuring 1 million unique visitors per month + continuously updated news database of 37 million articles in 12 world languages from 166,000 global and weighted sources + 2.1 billion metadata * To seize this unique chance, contact invest@newstin.com. * Newstin.com is for sale! *
Full Coverage

InterMune to Present at BMO Healthcare Conference

emediaworld.com
Jul 30, 2008
        
Story Timeline:  69 days

BRISBANE, Calif., July 30 /eMediaWorld/ -- InterMune, Inc. (Nasdaq: ITMN) today announced that Daniel G. Welch, Chairman, CEO and President of InterMune, will present at the BMO Capital Markets 2008 Focus on Healthcare Conference in New York on August 6, 2008 at 10:00 a.m. EDT. To access a live audio webcast of the presentation, investors and other interested parties may log on to the investor relations page of InterMune's corporate website at http://www.intermune.com. The company recommends logging on to the site 15 minutes prior to the start of the presentation in order to register or download any necessary software. About InterMune InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and hepatology. InterMune has a research and development... [read full story]                    

Add Comment
Latest article on this story:

InterMune Reports Second Quarter 2008 Financial Results and Business Highlights (PR Newswire)

 yahoo.com Jul 31, 2008
First article on this story:

InterMune to Present at BMO Healthcare Conference

 prnewswire.com Jul 30, 2008
Selected publications with coverage of this story:
redorbit.com prnewswire.com yahoo.com emediaworld.com
RELATED
Found 4 documents:
                   

InterMune Reports Second Quarter 2008 Financial Results and Business Highlights (PR Newswire)

yahoo.com
Jul 31, 2008
        

Thursday July 31, 4:01 pm ET - We reported substantial progress on our collaboration with Roche with ITMN-191 (R7227) by reporting top-line results from our 14-day monotherapy study, reporting the successful completion of...

                   

InterMune Reports Second Quarter 2008 Financial Results and Business Highlights

prnewswire.com
Jul 31, 2008
        

InterMune Reports Second Quarter 2008 Financial Results and Business Highlights - InterMune, Inc. (Nasdaq: ITMN) today announced results from operations for the second quarter and six months ended June 30, 2008. At the AASLD...

InterMune to Present at BMO Healthcare Conference

redorbit.com
Jul 30, 2008
        

BRISBANE, Calif., July 30 /PRNewswire-FirstCall/ -- InterMune, Inc. today announced that Daniel G. Welch, Chairman, CEO and President of InterMune, will present at the BMO Capital Markets 2008 Focus on Healthcare Conference in...

InterMune to Present at BMO Healthcare Conference (PR Newswire)

yahoo.com
Jul 30, 2008
        

Wednesday July 30, 4:01 pm ET BRISBANE, Calif., July 30 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN - News ) today announced that Daniel G. Welch, Chairman, CEO and President of InterMune, will present at the BMO...